Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Other Non Operating Income came in at $23.0 million in Q1 2026, up 95795.83% YoY from N/an in Q1 2025, and up 245.85% on a QoQ basis from -$15.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Other Non Operating Income data on file, last reported at $23.0 million in Q1 2026.
- Quarterly Other Non Operating Income rose 95795.83% year-over-year to $23.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 526.12% YoY) and the FY2025 annual result came in at $8.4 million, up 191.82% from the prior year.
- Other Non Operating Income advanced to $23.0 million in Q1 2026, from -$15.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $38.1 million in Q3 2025 to a low of -$16.2 million in Q4 2023.
- A 5-year average of $618529.4 and a median of -$290000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 1296.56% — and 2026, when it jumped 95795.83%.
- Tracing GTBIF's Other Non Operating Income over 5 years: stood at -$10.4 million in 2022, then sank by 55.55% to -$16.2 million in 2023, then jumped by 41.44% to -$9.5 million in 2024, then tumbled by 65.67% to -$15.7 million in 2025, then surged by 245.85% to $23.0 million in 2026.
- The last three Other Non Operating Income figures came in at $23.0 million (Q1 2026), -$15.7 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Green Thumb Industries | 1.66 Bn | 1.37 Bn | 137.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.22 Mn |
| Mar 31, 2026 | 22.97 Mn |
| Dec 31, 2025 | -15.75 Mn |
| Sep 30, 2025 | 38.11 Mn |
| Jun 30, 2025 | -13.99 Mn |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | -9.51 Mn |
| Sep 30, 2024 | -290,000.00 |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | -1.76 Mn |
| Dec 31, 2023 | -16.23 Mn |
| Sep 30, 2023 | -631,000.00 |
| Jun 30, 2023 | -270,000.00 |
| Mar 31, 2023 | 924,000.00 |
| Dec 31, 2022 | -10.43 Mn |
| Sep 30, 2022 | -2.09 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 11.44 Mn |
| Dec 31, 2021 | 872,000.00 |
| Jun 30, 2021 | 6.83 Mn |